Author

V. Palzkill

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Physiology· 3

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Organism:mouse· 3 Assay:bulk RNA-seq· 2 Research Focus:cell type annotation· 2 Research Focus:cell signaling & trafficking· 1 Research Focus:differential expression· 1 Research Focus:host-pathogen & immune response· 1 Assay:imaging· 1

Frequent Co-Authors

J. Tan· 3 shared T. E. Ryan· 3 shared L. F. Ferreira· 2 shared Q. Yang· 2 shared A. L. Tice· 1 shared A. Murillo· 1 shared C. G. Pass· 1 shared C. Moparthy· 1 shared

Activity by Year

2023-2024 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 34 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersPhysiology

J. Tan

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

A 6-minute Limb Function Assessment for Therapeutic Testing in Experimental Peripheral Artery Disease Models

V. Palzkill, J. Tan, A. L. Tice, L. F. Ferreira, T. E. Ryan

This paper develops a 6-minute limb function test for preclinical hindlimb ischemia models to assess muscular performance and hemodynamics, showing it detects therapeutic differences better than traditional measures.

bioRxiv · Mar 21, 2024Physiology

Activation of the Aryl Hydrocarbon Receptor in Endothelial Cells Impairs Ischemic Angiogenesis in Chronic Kidney Disease

V. Palzkill, J. Tan, Q. Yang, J. Morcos, O. Laitano, T. E. Ryan

This study shows that deleting the AHR in endothelial cells improves ischemic angiogenesis in male CKD mice but not females, revealing sex-dependent differences in AHR activation and angiogenic signaling.

bioRxiv · Jul 24, 2023 · PreprintPhysiology

Chronic activation of the aryl hydrocarbon receptor in muscle exacerbates ischemic pathology in chronic kidney disease

N. Balestrieri, V. Palzkill, C. G. Pass, J. Tan, Z. R. Salyers, C. Moparthy, A. Murillo, K. Kim, T. Thome, Q. Yang, K. O'Malley, S. A. Berceli, F. Yue, S. T. Scali, L. F. Ferreira, T. E. Ryan

This study shows chronic AHR activation in muscle worsens ischemic damage in CKD and PAD by impairing muscle function and mitochondrial health.

bioRxiv · May 16, 2023Physiology